Addiction treatment provider BayMark Health Services is expanding again via acquisition, as its affiliate AppleGate Recovery has purchased Indianapolis-based Lucina Treatment Centers.

Established in 2016, Lucina operates five clinics for opioid use disorder (OUD) treatment throughout central and northeastern Indiana, which includes two locations in its Indianapolis homebase as well as three facilities in Kokomo, Fort Wayne and Muncie.

Lucina provides medication-assisted treatment (MAT) drugs like buprenorphine and vivitrol along with other services such as group and individual counseling, alcohol cessation and methadone transition.

The provider has previously not accepted insurance but states on its website that it plans to do so soon.

“There is no state, county or city in this country that hasn’t been touched by the opioid epidemic,” AppleGate Recovery President Michael Saul said in a press release.

AppleGate Recovery operates outpatient OUD treatment programs in Arkansas, Kentucky, Louisiana, Ohio, Pennsylvania, Tennessee, Texas, Virginia and West Virginia.

“BayMark is proud to be bringing its expertise and support to these programs as they continue to do life-saving work in areas with significant need of opioid addiction treatment services,” Saul added.

Headquartered in Lewisville, Texas, BayMark operates over 350 addiction treatment clinics across 36 states and three Canadian provinces. In addition to MAT drugs, BayMark also provides counseling and sober living options to patients, along with offering intensive outpatient and partial hospitalization programming.

BayMark currently provides OUD treatment to Indiana residents through two programs under its MedMark Treatment Centers brand, which are located in Lafayette and Kokomo. BayMark also operates the OUD treatment program Northwest Indiana Treatment Center, which is located in Merrillville and offers MAT drug assistance through suboxone and methadone.

With the Lucina purchase, BayMark – which bills itself as the nation’s largest treatment provider for OUD – now operates 50 office-based opioid treatment programs across 13 states. Similar to Lucina, BayMark offers patients the MAT drug vivitrol along with providing suboxone.

BayMark’s snapping up of Lucina follows similar patterns of growth for the provider over the last year through purchases of smaller regional brands. Among BayMark’s transactions include its purchase late last year of New Hampshire-based Granite Recovery Services, its acquisition last summer of Louisiana-based New Day Recovery and its deal last May for West Virginia-based Hope for Tomorrow.

BayMark is owned by Webster Equity Partners, which has furthered its own investment into the behavioral health space with the announcement last week that it had become a new capital partner for Oceans Healthcare.

Terms of BayMark’s deal for Lucina were not disclosed.